Pharmacokinetic and technical comparison of Sandostatin(® )LAR(® )and other formulations of long-acting octreotide

BACKGROUND: Sandostatin(® )LAR(® )(Novartis Pharma AG) is a long-acting repeatable formulation of the somatostatin analogue octreotide, the safety and efficacy of which has been established through 15 years of clinical experience. Recently, other formulations of octreotide using polymer poly(lactic-...

Full description

Saved in:
Bibliographic Details
Main Authors: Petersen, Holger, Bizec, Jean-Claude, Schuetz, Helmut, Delporte, Marie-Laure
Format: Artigo
Language:Inglês
Published: BioMed Central 2011
Subjects:
Short Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3212992/
https://ncbi.nlm.nih.gov/pubmed/21906300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-0500-4-344
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items